Home » Stocks » Axogen

Axogen, Inc. (AXGN)

Stock Price: $12.22 USD 0.18 (1.50%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 485.89M
Revenue (ttm) 107.69M
Net Income (ttm) -27.82M
Shares Out 39.76M
EPS (ttm) -0.71
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $12.22
Previous Close $12.04
Change ($) 0.18
Change (%) 1.50%
Day's Open 12.03
Day's Range 11.98 - 12.38
Day's Volume 291,385
52-Week Range 7.16 - 18.84

More Stats

Market Cap 485.89M
Enterprise Value 399.83M
Earnings Date (est) Oct 28, 2020
Ex-Dividend Date n/a
Shares Outstanding 39.76M
Float 25.95M
EPS (basic) -0.71
EPS (diluted) -0.71
FCF / Share -0.71
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.27M
Short Ratio 2.69
Short % of Float 5.25%
Beta 0.48
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 4.51
PB Ratio 3.64
Revenue 107.69M
Operating Income -29.71M
Net Income -27.82M
Free Cash Flow -28.26M
Net Cash 86.07M
Net Cash / Share 2.16
Gross Margin 82.98%
Operating Margin -27.59%
Profit Margin -25.80%
FCF Margin -26.25%
ROA -11.60%
ROE -21.00%
ROIC -27.80%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (6)

Buy 4
Overweight 0
Hold 2
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$16.30*
(33.39% upside)
Low
13.0
Current: $12.22
High
22.0
Target: 16.30
*Average 12-month price target from 5 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue10783.9460.4341.1127.3316.8210.957.694.853.00
Revenue Growth27.13%38.91%46.99%50.41%62.52%53.62%42.33%58.61%61.41%-
Gross Profit89.3671.0151.1234.6422.4813.388.515.732.421.63
Operating Income-31.41-20.50-7.95-8.13-9.27-9.80-9.59-7.80-6.97-4.48
Net Income-29.14-22.40-10.45-14.41-13.36-17.71-14.56-9.42-9.22-5.42
Shares Outstanding39.2437.1333.3230.7026.0817.7213.5011.093.700.84
Earnings Per Share-0.74-0.60-0.31-0.47-0.51-0.99-1.08-0.85-2.77-8.35
Operating Cash Flow-19.87-17.86-9.24-11.24-13.05-10.45-10.44-8.66-7.08-3.94
Capital Expenditures-4.66-6.28-1.11-0.93-0.41-0.54-0.18-0.05-0.02-
Free Cash Flow-24.54-24.14-10.34-12.17-13.46-10.99-10.62-8.71-7.10-3.94
Cash & Equivalents10312336.5130.0125.918.2220.0713.918.191.80
Total Debt3.330.0624.5524.3124.7025.0925.3621.584.848.42
Net Cash / Debt99.1812311.965.701.21-16.87-5.29-7.673.35-6.62
Assets15516058.8846.3636.7016.4027.6820.2312.506.41
Liabilities22.4913.1933.6931.4428.5027.6527.5523.066.4218.11
Book Value13214725.1814.928.20-11.250.14-2.836.07-27.11
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Axogen, Inc.
Country United States
Employees 371
CEO Karen L. Zaderej

Stock Information

Ticker Symbol AXGN
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: AXGN

Description

AxoGen, Inc., together with its subsidiaries, provides surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues in the surgical bed. In addition, the company offers AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. It provides its products to hospitals, surgery centers, and military hospitals plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons in the United States, Canada, the United Kingdom and other European countries, South Korea, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.